Invanz and Arrhythmias - a phase IV clinical study of FDA data

Summary:

Arrhythmias is reported as a side effect among people who take Invanz (ertapenem sodium), especially for people who are female, 60+ old, have been taking the drug for < 1 month also take Zometa, and have Traumatic injury of the bladder and urethra.

The phase IV clinical study analyzes which people have Arrhythmias when taking Invanz. It is created by eHealthMe based on reports of 3,924 people who have side effects when taking Invanz from the FDA, and is updated regularly.

What is Invanz?

Invanz has active ingredients of ertapenem sodium. It is often used in urinary tract infection. eHealthMe is studying from 3,961 Invanz users. Check the latest studies of Invanz.

What is Arrhythmias?

Arrhythmias (irregular heartbeat) is found to be associated with 2,758 drugs and 4,837 conditions by eHealthMe. Check the latest studies of Arrhythmias.

On Jul, 13, 2026

3,924 people reported to have side effects when taking Invanz.
Among them, 54 people (1.38%) have Arrhythmias.

Among these 54 people:

How long have people been on Invanz when they have Arrhythmias? *

What is the gender of people who have Arrhythmias when taking Invanz? *

female: 69.81 %
male: 30.19 %

What is the age of people who have Arrhythmias when taking Invanz? *

What are other drugs people take besides Invanz? *

What are other side effects people have besides Arrhythmias? *

High Blood Pressure: 21 people, 38.89%
Stress And Anxiety: 20 people, 37.04%
Spinal Osteoarthritis (joint cartilage loss in spine): 20 people, 37.04%
Osteonecrosis Of Jaw (death of bone of jaw): 20 people, 37.04%
Arthritis (form of joint disorder that involves inflammation of one or more joints): 18 people, 33.33%
Oedema Peripheral (superficial swelling): 17 people, 31.48%
Abdominal Pain: 15 people, 27.78%
Pneumonia: 15 people, 27.78%
Anaemia (lack of blood): 14 people, 25.93%
Joint Pain: 14 people, 25.93%

What are the existing conditions these people have? *

Traumatic Injury Of The Bladder And Urethra: 7 people, 12.96%
Metastases To Bone (cancer spreads to bone): 6 people, 11.11%
Diabetes: 3 people, 5.56%
High Blood Pressure: 3 people, 5.56%
Kidney Infection (Pyelonephritis): 3 people, 5.56%
Hypothyroidism (abnormally low activity of the thyroid gland, resulting in retardation of growth and mental development): 2 people, 3.70%
Osteomyelitis (infection of bone): 2 people, 3.70%
Short-Bowel Syndrome (a condition in which the body cannot absorb enough fluids and nutrients because part of the small intestine is missing): 2 people, 3.70%
Metastatic Malignant Melanoma (spreadable cancer tumour of melanine): 2 people, 3.70%
Appendicitis Perforated (perforated appendicitis is a condition in which an inflamed appendix bursts): 1 person, 1.85%

* Approximation only. Some reports may have incomplete information.

Do you take Invanz and have Arrhythmias?

- Check whether Arrhythmias is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Invanz:

Invanz (3,961 reports)

Arrhythmias treatments and more:

Arrhythmias (177,908 reports)

Browse all side effects of Invanz:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Arrhythmias:

Arrhythmias (2,758 drugs)

Browse all the conditions that are associated with Arrhythmias:

Arrhythmias (4,837 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on ertapenem sodium (the active ingredients of Invanz) and Invanz (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.